Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop (2017)
Chapter: 5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials
Visit
NAP.edu/10766
to get more information about this book, to buy it in print, or to
download it as a free PDF.
Previous Chapter:
4 New Modeling Approaches for Nervous System Disorders
Next Chapter: 6 Ethical Considerations
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
There was a problem loading page 33.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
There was a problem loading page 34.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
There was a problem loading page 35.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
There was a problem loading page 36.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
There was a problem loading page 37.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
There was a problem loading page 38.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
There was a problem loading page 39.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
There was a problem loading page 40.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
There was a problem loading page 41.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
There was a problem loading page 42.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
There was a problem loading page 43.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
There was a problem loading page 44.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
Suggested Citation:
"5 Private-Sector Thresholds for Investment in Neuroscience Clinical Trials." National Academies of Sciences, Engineering, and Medicine. 2017. Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/24672.
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.